Document Detail

Impact of statin therapy on coronary intervention for non-ST elevation acute coronary syndrome with decreased low-density lipoprotein cholesterol.
MedLine Citation:
PMID:  17444137     Owner:  NLM     Status:  MEDLINE    
OBJECTIVES: The benefits of treating patients with acute coronary syndrome (ACS) with statins are well established. This study investigated the effects of statins on patients who presented with low levels of low-density lipoprotein (LDL) cholesterol, were diagnosed with non-ST elevation ACS, and subsequently underwent percutaneous coronary interventions (PCI). METHODS: From 2000 to 2003, 87 patients(mean age 68 +/- 10 years, 69 males, 18 females) underwent PCI because of non-ST elevation ACS, and had low LDL cholesterol on presentation. These patients were divided into two groups: those who had been taking statins (S-group, n = 46), and those not taking statins, or controls (C-group, n = 41). Only patients whose LDL cholesterol was < 100 mg/dl at admission (average: 82 +/- 12 mg/dl) were included in the study. Troponin-T (TnT), creatine kinase (CK), CK-MB, and high-sense C reactive protein (hs-CRP) were measured before and 6 hr after PCI. The two groups were evaluated at 6 months clinical follow-up. RESULTS: There was no difference in these markers before PCI in both groups. TnT and CK-MB in the S-group at 6 hr post-PCI were significantly decreased compared to those of the C-group (0.45 +/- 1.34 vs 1.40 +/- 2.37 ng/ml, respectively, for TnT, p = 0.04; 17.2 +/- 45.5 vs 81.3 +/- 157.2 IU/l, respectively, for CK-MB, p = 0.02). Major adverse cardiac events (MACE) defined as death, myocardial infarction, congestive heart failure and target lesion revascularization were evaluated after 6 months. There was no difference in MACE between the two groups. CONCLUSIONS: Statin treatment before PCI in patients with non-ST elevation ACS demonstrated beneficial effects such as less myocardial damage, even though both groups presented with low LDL cholesterol levels. However, no significant effect on MACE was seen at 6 months after PCI.
Hidehiko Hara; Masato Nakamura; Itaru Yokouchi; Keiko Kimura; Naohiko Nemoto; Shingo Ito; Tsuyoshi Ono; Masanori Shiba; Masamichi Wada; Takahiro Tsuji; Hirotaka Komatsu; Raisuke Iijima; Rintaro Nakajima; Masaya Yamamoto; Masato Yamamoto; Takashi Yoshitama; Takuro Takagi; Hisao Hara; Kaoru Sugi
Related Documents :
3258157 - Familial aggregation of coronary heart disease: partial mediation by high density lipop...
10740137 - Statins: effective antiatherosclerotic therapy.
15604317 - Statins for heart failure: at the crossroads between cholesterol reduction and pleiotro...
10327777 - Lipid profile of coronary risk subjects following yogic lifestyle intervention.
18926147 - Efficacy of low-dose dobutamine stress-echocardiography to predict cardiac resynchroniz...
3678847 - Thrombolytic therapy in acute myocardial infarction in the elderly.
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Journal of cardiology     Volume:  49     ISSN:  0914-5087     ISO Abbreviation:  J Cardiol     Publication Date:  2007 Mar 
Date Detail:
Created Date:  2007-04-20     Completed Date:  2007-06-01     Revised Date:  2007-11-15    
Medline Journal Info:
Nlm Unique ID:  8804703     Medline TA:  J Cardiol     Country:  Japan    
Other Details:
Languages:  eng     Pagination:  115-23     Citation Subset:  IM    
Minneapolis Heart Institute and Foundation, 920 East 28th Street Suite 620, Minneapolis, MN 55407, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Angioplasty, Transluminal, Percutaneous Coronary*
Cholesterol, LDL / blood*
Coronary Angiography
Coronary Artery Disease / blood*,  drug therapy,  therapy*
Hydroxymethylglutaryl-CoA Reductase Inhibitors / therapeutic use*
Middle Aged
Reg. No./Substance:
0/Cholesterol, LDL; 0/Hydroxymethylglutaryl-CoA Reductase Inhibitors

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Correlation between exercise electrocardiography test and coronary flow reserve in patients without ...
Next Document:  Left ventricular volume and ejection fraction by the axius auto ejection fraction method: comparison...